- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.11. | Simris Group AB receives observation status | 67 | GlobeNewswire | Today, November 12, 2025, Simris Group AB (the "Company") disclosed its interim report for the third quarter of 2025 with information on the Company's financial situation.
The rules of Nasdaq... ► Artikel lesen | |
| 12.11. | Simris Group AB: Simris Group Interim Report January-september 2025 | 65 | GlobeNewswire (Europe) | QUARTER 3, JULY - SEPTEMBER 2025Net revenue decreased by 37% to SEK 484k (766k).EBITDA declined by 22% to SEK -3 639k (-2 971k).EBIT/Operating result declined by 8% to SEK -7 152k (-6 614k).INTERIM... ► Artikel lesen | |
| 10.11. | Simris Group AB: Simris Group announces leadership transition - Daniel Kubitza appointed interim CEO | 99 | GlobeNewswire (Europe) | The Board of Directors of Simris Group has appointed Daniel Kubitza as interim CEO, effective immediately.
Daniel Kubitza has over 20 years of experience in corporate financing, commercialization and... ► Artikel lesen | |
| 05.11. | Simris Group AB: Simris Group AB Announces Positive Results from Ongoing Antibody-Drug Conjugate (ADC) Study with Nuvisan | 93 | GlobeNewswire (Europe) | Simris Group AB's wholly owned subsidiary, Simris Biologics GmbH, today announced important progress in its ongoing preclinical study with Nuvisan, a leading European contract research and development... ► Artikel lesen | |
| 06.10. | Simris Group AB: Update Regarding In-Vitro Evaluation of Novel Advance Microcystin Payloads | 162 | GlobeNewswire (Europe) | Simris Group AB wholly owned subsidiary, Simris Biologics GmbH, today announced short technical delays in a previously announced study contracted with Nuvisan, a leading European contract research and... ► Artikel lesen | |
| 12.09. | Simris Group AB: Simris Biologics awarded €200K in non-dilutive funding for R&D programme to further develop microcystin payloads for Antibody Drug Conjugates (ADCs) | 793 | GlobeNewswire (Europe) | Simris Group AB, a pioneer in the development of novel, next-generation Antibody Drug Conjugate (ADC) payloads based on Microcystin (MC) toxin variants, announces that funding has been approved for... ► Artikel lesen | |
| 13.08. | Simris Group AB: Simris Group Interim Report January-june 2025 | 153 | GlobeNewswire (Europe) | QUARTER 2, APRIL - JUNE 2025Net revenue increased by 8% to SEK 687k (634k).EBITDA improved by 51% to SEK -2 980k (-6 117k).EBIT/Operating result improved by 32% to SEK -6 693k (-9 822k).INTERIM PERIOD... ► Artikel lesen | |
| 14.07. | Simris Group AB: Partner Company Decides Not to Proceed with Simris Group ADC Proposed Collaboration Following Strategic Review | 141 | GlobeNewswire (Europe) | Simris Group AB (publ), through its subsidiary Simris Biologics GmbH, announces that the EU-based biopharmaceutical company with which it had signed a non-binding concept sheet for a potential antibody-drug... ► Artikel lesen | |
| SIMRIS GROUP Aktie jetzt für 0€ handeln | |||||
| 28.05. | Simris Group AB: Bulletin from Simris Group AB's annual general meeting | 266 | GlobeNewswire (Europe) | Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held its annual general meeting on 28 May 2025. Below follows a summary of the resolutions that were passed at the general meeting.
Income... ► Artikel lesen | |
| 14.05. | Simris Group AB: Simris Group Interim Report January-march 2025 | 311 | GlobeNewswire (Europe) | QUARTER 1, JANUARY - MARCH 2025Net revenue decreased by 69 percent to SEK 159k (519k).EBITDA improved by 30 percent to SEK -3 724k (-5 325k). EBIT/ operating result improved by 19 percent to SEK -7... ► Artikel lesen | |
| 26.02. | Simris Group AB: Simris Group Year-end Report January-december 2024 | 194 | GlobeNewswire (Europe) | QUARTER 4, OCTOBER - DECEMBER 2024Net revenue decreased by 63 percent to SEK 971k (2 657k).EBITDA improved by 41 percent to SEK -3 180k (-5 403k).EBIT/Operating result deteriorate by 6 percent to SEK... ► Artikel lesen | |
| 04.02. | The observation status for Simris Group AB is removed | 306 | GlobeNewswire | On October 24, 2024, the shares in Simris Group AB (the "Company") were given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
On... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BEYOND MEAT | 0,890 | +2,51 % | Beyond Meat, Inc.: Beyond Meat Announces Determination of Conversion Rate for 7.00% Convertible Senior Secured Second Lien PIK Toggle Notes due 2030 | EL SEGUNDO, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ: BYND) (the "Company" or "Beyond Meat"), a leader in plant-based meat, today announced the initial conversion rate for... ► Artikel lesen | |
| OATLY GROUP | 10,550 | -1,40 % | Nach einer langen Durststrecke stellt Oatly wieder Gewinne in Aussicht und auch die Aktie schlägt sich wieder besser | Nur etwas mehr als vier Jahre liegt der Börsengang von Oatly zurück, der von viel Euphorie begleitet wurde. Der Aktienkurs schoss zeitweise auf mehr als 500 US-Dollar in die Höhe und nach oben schien... ► Artikel lesen | |
| CONAGRA BRANDS | 15,054 | +0,28 % | Passives Einkommen: Conagra: Stabiler Cashflow und beeindruckende 8 % Rendite | © Foto: DALL-EDie Aktie von Conagra Brands ist tief gefallen - doch ihre hohe Dividendenrendite weckt neues Interesse. Dank starker Marken und solider Bilanzen ist der Konsumriese ein zuverlässiger... ► Artikel lesen | |
| AGRARIUS | - | - | Agrarius AG: "Konzernjahresfehlbetrag sinkt von 2,37 auf 1,98 Mio. Euro - 221 Hektar Ackerland im Eigentum" - HV-Bericht von GSC-Research | - im Anhang finden Sie den HV-Bericht von GSC-Research.Anhang: HVAGRARIUS2025.pdfDen vollständigen Artikel lesen ... ► Artikel lesen | |
| WINGSTOP | 198,00 | -1,00 % | Wingstop Restaurants Inc.: Wingstop Inc. Reports Fiscal Third Quarter Financial Results | Record 114 Net New Openings in Third Quarter, 19.3% Net New Unit Growth
Adjusted EBITDA Growth of 18.6% to $63.7 million, Highest Quarter on Record
DALLAS, Nov.... ► Artikel lesen | |
| WH GROUP | 0,925 | -1,07 % | HSI Down 500 pts; HSTI Down 168 pts; BABA Down over 4%; WH GROUP Hit New Highs; Market Turnover Rises | ||
| ELSE NUTRITION | 0,069 | 0,00 % | Else Nutrition Holdings Inc.: Else Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based ... | New Federal Budget Agreement Ends Government Shutdown and Expedites FDA Pathway for Innovative, Non-Soy, Plant-Based Infant Nutrition Under Operation Stork Speed... ► Artikel lesen | |
| MHP | 5,000 | +8,70 % | MHP SE executive purchases GDRs worth nearly $20,000 | ||
| BIOGAIA | 9,235 | +0,38 % | BioGaia AB and University of Gothenburg discovered a new role for bacteria present in the gut: serotonin production | Often considered as our "second brain", the human gut and its resident microbiota play a crucial bidirectional role communicating the brain (central nervous system) with the gut (enteric nervous system)... ► Artikel lesen | |
| JACK IN THE BOX | 12,300 | -0,81 % | Jack In The Box Q4 2025 Earnings Preview | ||
| J&J SNACK FOODS | 76,50 | +6,99 % | J&J Snack Foods to close three plants under Project Apollo transformation | ||
| KURA SUSHI USA | 46,090 | 0,00 % | Kura Sushi USA Announces Fiscal Fourth Quarter and Fiscal Year 2025 Financial Results | IRVINE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Kura Sushi USA, Inc. ("Kura Sushi" or the "Company") (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced financial results... ► Artikel lesen | |
| CALAVO GROWERS | 19,030 | 0,00 % | Calavo Growers, Inc.: Calavo Growers Announces Leadership Transition | Lee E. Cole to retire following four decades of distinguished leadership B. John Lindeman appointed President and Chief Executive Officer SANTA PAULA, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Calavo... ► Artikel lesen | |
| CAVA GROUP | 45,020 | 0,00 % | Citi rechnet mit Umsatzschub nach Regierungsstillstand: Aktien von Cava und Sweetgreen im Aufwind | ||
| NESTLE | 85,70 | -0,16 % | Perrier-Eklat: Trotz Skandal: Nestlé gewinnt vor Gericht | © Foto: Laurent Gillieron/KEYSTONE/dpaNestlé darf Perrier weiter verkaufen: Ein Gericht wies die Klage wegen irreführender Werbung ab. Trotz starker Kritik bleibt das Wasser im Handel.Nestlé hat im... ► Artikel lesen |
Das Unternehmen SIMRIS GROUP AB kann der Branche Nahrungsmittel/Agrar zugeordnet werden. Der aktuelle Kurs liegt bei 0,004 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SIMRIS GROUP AB finden Sie auf Wallstreet Online.